Mobile Trading

TRANSGENE BIOTEK LTD.

NSE : NABSE : 526139ISIN CODE : INE773D01018Industry : Hospital & Healthcare ServicesHouse : Private
BSE3.100.02 (+0.65 %)
PREV CLOSE ( ) 3.08
OPEN PRICE ( ) 2.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 12023
TODAY'S LOW / HIGH ( )2.90 3.14
52 WK LOW / HIGH ( ) 2.98
Quarters
Select year  
( in Million)
Particulars
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Audited / UnAudited
UnAudited
Audited
Audited
UnAudited
Net Sales
0.53
0.5
0.77
0.77
Total Expenditure
1.27
1.88
6.18
1.69
PBIDT (Excl OI)
-0.74
-1.38
-5.41
-0.92
Other Income
NA
NA
0.44
0.44
Operating Profit
-0.74
-1.38
-4.98
-0.49
Interest
2.64
2.46
1.91
0.17
Exceptional Items
NA
NA
NA
NA
PBDT
-3.38
-3.84
-6.89
-0.66
Depreciation
0.5
0.5
0.24
0.23
Profit Before Tax
-3.88
-4.34
-7.13
-0.89
Tax
NA
NA
NA
NA
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-3.88
-4.34
-7.13
-0.89
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-3.88
-4.34
-7.13
-0.89
Minority Interest
NA
NA
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-3.88
-4.34
-7.13
-0.89
Equity Capital
757.7
757.7
757.7
757.7
Face Value (IN RS)
10
10
10
10
Reserves
NA
NA
NA
NA
Calculated EPS
-0.05
-0.05
-0.09
-0.01
Calculated EPS (Annualised)
-0.20
-0.22
-0.37
-0.04
No of Public Share Holdings
53072098
53072098
53072098
53072098
% of Public Share Holdings
76.36
76.36
76.36
76.36
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
-139.62
-276
-702.59
-119.48
PBIDTM%
-139.62
-276
-646.75
-63.63
PBDTM%
-637.73
-768
-894.80
-85.71
PBTM%
-732.07
-868
-925.97
-115.58
PATM%
-732.07
-868
-925.97
-115.58
 
Notes
Notes
Notes
Notes

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.